{"id":"https://openalex.org/W2017389884","doi":"https://doi.org/10.1021/cc0301014","title":"High-Speed Optimization of Inhibitors of the Malarial Proteases Plasmepsin I and II","display_name":"High-Speed Optimization of Inhibitors of the Malarial Proteases Plasmepsin I and II","publication_year":2003,"publication_date":"2003-05-17","ids":{"openalex":"https://openalex.org/W2017389884","doi":"https://doi.org/10.1021/cc0301014","mag":"2017389884","pmid":"https://pubmed.ncbi.nlm.nih.gov/12857114"},"language":"en","primary_location":{"id":"doi:10.1021/cc0301014","doi":"https://doi.org/10.1021/cc0301014","is_oa":false,"landing_page_url":"https://doi.org/10.1021/cc0301014","pdf_url":null,"source":{"id":"https://openalex.org/S4210175341","display_name":"Journal of Combinatorial Chemistry","issn_l":"1520-4766","issn":["1520-4766","1520-4774"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Combinatorial Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066930684","display_name":"Daniel N\u00f6teberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]},{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Daniel N\u00f6teberg","raw_affiliation_strings":["Department of Organic Pharmaceutical Chemistry, BMC, Uppsala University, Box 574, SE-751 23 Uppsala, Sweden, and Medivir AB, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Organic Pharmaceutical Chemistry, BMC, Uppsala University, Box 574, SE-751 23 Uppsala, Sweden, and Medivir AB, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":["https://openalex.org/I123387679","https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091859168","display_name":"Wesley Schaal","orcid":"https://orcid.org/0000-0001-6770-0878","observed_orcids":["https://orcid.org/0000-0001-6770-0878"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]},{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Wesley Schaal","raw_affiliation_strings":["Department of Organic Pharmaceutical Chemistry, BMC, Uppsala University, Box 574, SE-751 23 Uppsala, Sweden, and Medivir AB, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Organic Pharmaceutical Chemistry, BMC, Uppsala University, Box 574, SE-751 23 Uppsala, Sweden, and Medivir AB, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":["https://openalex.org/I123387679","https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078930676","display_name":"Elizabeth Hamelink","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]},{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Elizabeth Hamelink","raw_affiliation_strings":["Department of Organic Pharmaceutical Chemistry, BMC, Uppsala University, Box 574, SE-751 23 Uppsala, Sweden, and Medivir AB, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Organic Pharmaceutical Chemistry, BMC, Uppsala University, Box 574, SE-751 23 Uppsala, Sweden, and Medivir AB, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":["https://openalex.org/I123387679","https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086480661","display_name":"Lotta Vrang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]},{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Lotta Vrang","raw_affiliation_strings":["Department of Organic Pharmaceutical Chemistry, BMC, Uppsala University, Box 574, SE-751 23 Uppsala, Sweden, and Medivir AB, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Organic Pharmaceutical Chemistry, BMC, Uppsala University, Box 574, SE-751 23 Uppsala, Sweden, and Medivir AB, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":["https://openalex.org/I123387679","https://openalex.org/I4210088043"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008347976","display_name":"Mats Larhed","orcid":"https://orcid.org/0000-0001-6258-0635","observed_orcids":["https://orcid.org/0000-0001-6258-0635"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]},{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Mats Larhed","raw_affiliation_strings":["Department of Organic Pharmaceutical Chemistry, BMC, Uppsala University, Box 574, SE-751 23 Uppsala, Sweden, and Medivir AB, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Organic Pharmaceutical Chemistry, BMC, Uppsala University, Box 574, SE-751 23 Uppsala, Sweden, and Medivir AB, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":["https://openalex.org/I123387679","https://openalex.org/I4210088043"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":10.0841,"has_fulltext":false,"cited_by_count":69,"citation_normalized_percentile":{"value":0.98243045,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"5","issue":"4","first_page":"456","last_page":"464"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10091","display_name":"Malaria Research and Control","score":0.913100004196167,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10091","display_name":"Malaria Research and Control","score":0.913100004196167,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.03610000014305115,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.01979999989271164,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/plasmepsin-ii","display_name":"plasmepsin II","score":1.0},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.9259999990463257},{"id":"https://openalex.org/keywords/focused-libraries","display_name":"focused libraries","score":0.6389999985694885},{"id":"https://openalex.org/keywords/microwave-assisted-synthesis","display_name":"microwave-assisted synthesis","score":0.8339999914169312},{"id":"https://openalex.org/keywords/combinatorial-optimization","display_name":"combinatorial optimization","score":0.824999988079071},{"id":"https://openalex.org/keywords/carboxylic-acids","display_name":"carboxylic acids","score":0.7839999794960022},{"id":"https://openalex.org/keywords/organometallic-reagents","display_name":"organometallic reagents","score":0.9129999876022339},{"id":"https://openalex.org/keywords/antimalarial-drugs","display_name":"antimalarial drugs","score":0.7149999737739563}],"concepts":[{"id":"https://openalex.org/C182220744","wikidata":"https://www.wikidata.org/wiki/Q7251226","display_name":"Proteases","level":3,"score":0.7244754433631897},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.6093783974647522},{"id":"https://openalex.org/C167844969","wikidata":"https://www.wikidata.org/wiki/Q426245","display_name":"Cathepsin","level":3,"score":0.6020035147666931},{"id":"https://openalex.org/C2780034444","wikidata":"https://www.wikidata.org/wiki/Q5052485","display_name":"Cathepsin L","level":4,"score":0.5799134969711304},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47954580187797546},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.4556465744972229},{"id":"https://openalex.org/C28021979","wikidata":"https://www.wikidata.org/wiki/Q14911946","display_name":"Cathepsin B","level":3,"score":0.4327632486820221},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.42906373739242554},{"id":"https://openalex.org/C118792377","wikidata":"https://www.wikidata.org/wiki/Q108584245","display_name":"Selectivity","level":3,"score":0.4173338711261749},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.4003775119781494},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.39368754625320435},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001713","descriptor_name":"Biphenyl Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002264","descriptor_name":"Carboxylic Acids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002402","descriptor_name":"Cathepsin D","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008401","descriptor_name":"Gas Chromatography-Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008872","descriptor_name":"Microwaves","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010963","descriptor_name":"Plasmodium falciparum","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010963","descriptor_name":"Plasmodium falciparum","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015800","descriptor_name":"Protozoan Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016282","descriptor_name":"Aspartic Acid Endopeptidases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D019151","descriptor_name":"Peptide Library","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020650","descriptor_name":"Combinatorial Chemistry Techniques","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1021/cc0301014","doi":"https://doi.org/10.1021/cc0301014","is_oa":false,"landing_page_url":"https://doi.org/10.1021/cc0301014","pdf_url":null,"source":{"id":"https://openalex.org/S4210175341","display_name":"Journal of Combinatorial Chemistry","issn_l":"1520-4766","issn":["1520-4766","1520-4774"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Combinatorial Chemistry","raw_type":"journal-article"},{"id":"pmid:12857114","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12857114","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of combinatorial chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1522940126","https://openalex.org/W1963790256","https://openalex.org/W1966715677","https://openalex.org/W1978890358","https://openalex.org/W1985236029","https://openalex.org/W1992850824","https://openalex.org/W2017422910","https://openalex.org/W2034137439","https://openalex.org/W2051709026","https://openalex.org/W2078771835","https://openalex.org/W2090178505","https://openalex.org/W2093094597","https://openalex.org/W2095573393","https://openalex.org/W4302590117"],"related_works":["https://openalex.org/W2093094597","https://openalex.org/W1991380804","https://openalex.org/W2071494467","https://openalex.org/W188321583","https://openalex.org/W2113526481","https://openalex.org/W1975099643","https://openalex.org/W2019251747","https://openalex.org/W1974040456","https://openalex.org/W2105004746","https://openalex.org/W2040164972"],"abstract_inverted_index":{"Four":[0],"focused":[1],"libraries":[2],"targeted":[3],"for":[4,59],"inhibition":[5],"of":[6,51,94,98],"the":[7,33,37,76,86,99,104,108],"malarial":[8],"proteases":[9],"plasmepsin":[10,68],"I":[11],"and":[12,18,23,39,53],"II":[13],"were":[14,30],"designed,":[15],"synthesized,":[16],"purified,":[17],"screened.":[19],"Selected":[20],"carboxylic":[21],"acids":[22],"organometallic":[24],"reactants":[25],"with":[26,45,72,82],"diverse":[27],"physical":[28],"properties":[29],"attached":[31],"to":[32,42],"hydroxylethylamine":[34],"scaffold":[35],"in":[36,75,103],"P3":[38],"P1'":[40,100],"positions":[41],"furnish":[43],"inhibitors":[44,69],"highly":[46],"improved":[47],"activity.":[48],"The":[49],"concept":[50],"controlled":[52],"sequential":[54],"microwave":[55],"heating":[56],"was":[57],"employed":[58],"rapid":[60],"library":[61],"generation.":[62],"This":[63],"combinatorial":[64],"optimization":[65],"protocol":[66],"afforded":[67],"not":[70],"only":[71],"K(i)":[73],"values":[74],"low":[77],"nanomolar":[78],"range,":[79],"but":[80],"also":[81],"high":[83],"selectivity":[84],"versus":[85],"human":[87],"protease":[88],"cathepsin":[89],"D.":[90],"With":[91],"this":[92],"class":[93],"inhibitory":[95],"agents,":[96],"modifications":[97],"substituents":[101],"resulted":[102],"largest":[105],"impact":[106],"on":[107],"plasmepsin/cathepsin":[109],"D":[110],"selectivity.":[111]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}